摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4-双(二氟甲氧基)苯胺 | 71791-36-1

中文名称
3,4-双(二氟甲氧基)苯胺
中文别名
——
英文名称
3,4-bis-difluoromethoxy-phenylamine
英文别名
3,4-Bis(difluoromethoxy)aniline
3,4-双(二氟甲氧基)苯胺化学式
CAS
71791-36-1
化学式
C8H7F4NO2
mdl
——
分子量
225.143
InChiKey
RNNUXPRMVLSPKO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    254.8±35.0 °C(Predicted)
  • 密度:
    1.387±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    44.5
  • 氢给体数:
    1
  • 氢受体数:
    7

SDS

SDS:bca4be03a14ea1c5b5a39ce7ef1f1b24
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,4-双(二氟甲氧基)苯胺硫酸 、 sodium carbonate 作用下, 以 乙醇溶剂黄146N,N-二甲基甲酰胺 为溶剂, 生成 1-(3,4-Bis-difluoromethoxy-phenyl)-6,7-difluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
    参考文献:
    名称:
    1-(二氟甲氧基苯基)喹诺酮-3-羧酸的合成及体外抗菌活性
    摘要:
    我们报道了其中二氟甲氧基部分被用作卤素替代物的N-1-苯基喹诺酮的合成。关于N-1-卤代苯基喹诺酮类药物的抗菌活性进行了讨论。
    DOI:
    10.1002/jps.2600780716
点击查看最新优质反应信息

文献信息

  • PHOSPHODIESTERASE 4 INHIBITORS
    申请人:HOPPER Allen T.
    公开号:US20100029689A1
    公开(公告)日:2010-02-04
    PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I: wherein R 1 , R 2 , R 3 , and R 4 are as defined herein.
    PDE4抑制是通过新颖的化合物实现的,例如N-取代苯胺和二苯胺类似物。本发明的化合物为Formula I:其中R1、R2、R3和R4如下所定义。
  • Chemical Compounds
    申请人:Barnes Michael Christopher
    公开号:US20080267914A1
    公开(公告)日:2008-10-30
    Compounds of formula (Ia) are found to be active in inhibiting replication of flaviviridae viruses (Ia), wherein R 1 and R 2 are the same or different and represent hydrogen, halogen, -L-O—R 3 , -L-O-L-A or -L-O-L′-A′, wherein each L is the same or different and represents a direct bond or a C 1 -C 4 alkylene group; L′ represents a direct bond or a C 2 -C 4 alkylene group; R 3 represents hydrogen, C 1 -C 4 alkyl or C 1 -C 4 haloalkyl; A represents a 5- to 10-membered heterocyclyl group; and A′ represents a C 6 -C 1 aryl group; wherein at least one of R 1 and R 2 is -L-O—R 3 , -L-O-L-A or -L-O-L′-A′.
    公式(Ia)的化合物被发现在抑制黄病毒科病毒(Ia)的复制方面具有活性,其中R1和R2相同或不同,表示氢、卤素、-L-O—R3、-L-O-L-A或-L-O-L′-A′,其中每个L相同或不同,表示直接键或C1-C4烷基链;L′表示直接键或C2-C4烷基链;R3表示氢、C1-C4烷基或C1-C4卤代烷基;A表示5-至10-成员杂环基团;A′表示C6-C1芳基基团;其中至少一个R1和R2是-L-O—R3、-L-O-L-A或-L-O-L′-A′。
  • Insecticidal heterolignans—Tubuline polymerization inhibitors with activity against chewing pests
    作者:Jens Frackenpohl、Isabelle Adelt、Horst Antonicek、Christian Arnold、Patricia Behrmann、Nicole Blaha、Jutta Böhmer、Oliver Gutbrod、Roman Hanke、Sabine Hohmann、Marc van Houtdreve、Peter Lösel、Olga Malsam、Martin Melchers、Valentina Neufert、Elisabeth Peschel、Udo Reckmann、Thomas Schenke、Hans-Peter Thiesen、Robert Velten、Kathrin Vogelsang、Hans-Christoph Weiss
    DOI:10.1016/j.bmc.2009.01.042
    日期:2009.6
    Starting from natural product podophyllotoxin 1 substituted heterolignans were identified with promising insecticidal in vivo activity. The impact of substitution in each segment of the core structure was investigated in a detailed SAR study, and variation of substituents in both aromatic moieties afforded derivatives 5 and 43 with broad insecticidal activity against lepidopteran and coleopteran species. In vitro measurements supported by modeling studies indicate that heterolignans 3-134 act as tubuline polymerization inhibitors interacting with the colchicine-binding site. Insect specific structure-activity effects were observed showing that the insecticidal SAR described herein differs from reported cytotoxicity studies. (C) 2009 Elsevier Ltd. All rights reserved.
  • KODZIMA, KADZUXIRO;ITO, XARUAKI
    作者:KODZIMA, KADZUXIRO、ITO, XARUAKI
    DOI:——
    日期:——
  • HETEROBICYCLIC METALLOPROTEASE INHIBITORS
    申请人:Steeneck Christoph
    公开号:US20120015920A1
    公开(公告)日:2012-01-19
    The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors.
查看更多